Abstract 6085: Engineered anti-CD40 agonist antibody as a novel cancer neoantigen vaccine carrier
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-6085
Abstract: Somatic mutations in cancer cells lead to the expression of neoantigens that can be targeted by personalized vaccines utilizing patient’s own host immune system to fight against cancer. However, current personalized cancer vaccines have shown… read more here.
Keywords: cancer; antibody; cd40 msas; vaccine ... See more keywords